Recursion Pharmaceuticals Company

Recursion Pharmaceuticals is a digital biology company, developing a drug discovery platform and pipeline with machine learning.

Invests into

Connections from

Last Funding Type: Post-IPO Equity
Total Funding: 665376000
Last Funding Date: 2023-07-12
Funding Status: IPO
Employee Number: 251-500
Estimated Revenue: $10M to $50M
Technology: ['BioTech & HealthTech']
Investors Number: 35
Founded Date: 2013-11-05
Headquarters: Salt Lake City, Utah, United States
Industry: Medical BioTech